Cardiovascular Disease

Mothers who experience preeclampsia, preterm delivery, gestational diabetes and other pregnancy complications also may be at increased risk for heart disease, according to researchers at Boston Medical Center.

Patients with rheumatoid arthritis who received tofacitinib demonstrated a greater risk for major adverse cardiovascular events and cancer than those treated with TNF inhibitors, according to data in The New England Journal of Medicine.

Current hydroxychloroquine use in patients with rheumatoid arthritis or systemic lupus erythematosus is associated with a reduced risk for cardiovascular events, including ischemic stroke and myocardial infarction, according to data.

Recent CDC data showed a modest decline in self-reported coronary heart disease in the U.S. between 2011 and 2018, though certain states and sociodemographic groups saw significant increases in prevalence.

The U.S. Preventive Services Task Force has issued a draft recommendation encouraging clinicians to use shared decision-making when considering behavioral counseling to promote healthy diet and physical activity for CVD prevention.

Patients with bullous pemphigoid experienced increases in cardiovascular mortality risk at 1, 3 and 5 years compared with matched controls, according to a study.

Diagnoses of cardiovascular issues plateaued during the COVID-19 pandemic, but diagnoses of cerebrovascular issues dropped sharply compared with pre-pandemic levels, per a population-based study published in Neurology.

Vitamin D3 supplementation, when taken in amounts that exceeded the recommended daily allowance, did not lower the occurrence of major CVD events or invasive cancer among older adults, data from a 5-year randomized controlled trial showed.

An electronic reminder sent to a provider ahead of a postpartum visit increased discussions about transition of care and CVD risk between the provider and patients who had a hypertensive disorder of pregnancy, researchers reported.